Universal Health Services, Inc. (UHS) — Fair Value Analysis

Base-case fair value (P50): $234.74 · Current price: $168.64 · Verdict: Undervalued

The Verdict on UHS

Universal Health Services (UHS), a prominent player in the Healthcare sector, appears significantly undervalued based on our latest Monte Carlo simulations. With a current market price of $169.96, our analysis indicates a median fair value (P50) of $237.26. This robust P50 suggests a substantial potential upside of +39.6% from its current trading level, strongly refuting any immediate perception of UHS being overvalued. The verdict of "undervalued" highlights a notable discrepancy between the market's current assessment and the asset's intrinsic worth derived from thousands of forward-looking scenarios. Investors should consider this significant spread when evaluating UHS.

How UHS stacks up against Healthcare

Despite the substantial potential upside indicated by the +39.6% gap, UHS holds an "average" quality tier when assessed for its operational and financial health relative to its sector peers. This mid-tier standing suggests that while the company isn't top-of-class across all performance metrics, its underlying business fundamentals are solid enough to support a valuation significantly higher than its current $169.96 price. The simulated median fair value of $237.26 reflects a robust outlook, even with an average quality profile, hinting at a compelling opportunity for investors who prioritize a strong margin of safety in their Healthcare sector exposures.

What this means for investors

The disparity between UHS’s current price of $169.96 and its median fair value of $237.26, representing a +39.6% gap, points to a compelling investment opportunity. Given the "undervalued" verdict, the current price appears to present a strong entry point, despite the company's average quality tier. This suggests that the market may be overlooking UHS's true potential. Investors seeking to understand the full range of possibilities, including specific bear-case and bull-case scenarios, can leverage FairCurve. Sign up for FairCurve to see the full bear/bull distribution and track UHS's fair value as new fundamentals are released.